Ventyx Biosciences Inc (VTYX)
13.98
+0.14%
Ventyx Biosciences Inc (VTYX) is currently trading at $13.98. This represents a gain of 0.14% from the previous session. With a market capitalization of $1.00B, VTYX is a key component of the Health Care sector. Investors looking to trade VTYX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade VTYX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Ventyx Biosciences Inc (VTYX) shows a bullish trend. Analysts are watching the 13.98 level closely.
Fundamentals
Mkt Cap1.00B
P/E Ratio0.0000
Volume164,673
60-Day Technical Chart
Advanced Charting
Need more indicators for VTYX? Use the world's #1 platform.
Open VTYX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $14
| Metric |
VTYX +0.14% |
F +1.87% |
AAL +1.37% |
SMR +0.07% |
|---|---|---|---|---|
| Price | $13.98 | $14.47 | $13.34 | $13.45 |
| Mkt Cap | $1.00B | $57.51B | $8.78B | $4.05B |
| - | View → | View → | View → |
Latest Headlines
With 57% ownership, Ventyx Biosciences, Inc. (NASDAQ:VTYX) boasts of strong institutional backing
Yahoo Finance • Nov 24, 2025
VTYX Stock Skyrockets 156% in a Month: Here's What You Need to Know - November 18, 2025
Zacks Investment Research • Nov 18, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
PR Newswire • Jan 15, 2026
Small Biotech Launches On Rumored $1 Billion Eli Lilly Buyout
Investor's Business Daily • Jan 6, 2026
Ventyx Biosciences (Nasdaq: VTYX) schedules Jefferies London fireside chat on Nov. 19
Stock Titan • Nov 17, 2025
● Gemini Agentic AI Analyst Insight for VTYX
Market Education
- Trump’s Latest Tariffs Send Shockwaves Across U.S. Economy Sep 26, 2025
- Are Cruise Stocks Finally Back on Course After a Rocky Five Years? Sep 27, 2025
- What do these rich Traders do - Peek into their day Jul 15, 2023
External Research